Štěpán Kouřil

Dr. Štěpán Kouřil

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2017 in Plant, Cell & Environment
Verified
Journal Article
Closed access
PDF file
OMOshry Markovich
Oshry Markovich
ESEvyatar Steiner
Evyatar Steiner
ŠKŠtěpán Kouřil
Štěpán Kouřil
Petr TarkowskiPetr Tarkowski
Petr Tarkowski
AAAsaph Aharoni
Asaph Aharoni
RERivka Elbaum
Rivka Elbaum

27 November 2019 in Planta
Verified
Journal Article
Closed access
PDF file
PJPavel Jaworek
Pavel Jaworek
Petr TarkowskiPetr Tarkowski
Petr Tarkowski
THTomáš Hluska
Tomáš Hluska
ŠKŠtěpán Kouřil
Štěpán Kouřil
OVOndřej Vrobel
Ondřej Vrobel
DKDavid Kopečný
David Kopečný

6 July 2016 in The Plant Cell
Verified
Journal Article
Open access
PDF file
MBMaya Bar
Maya Bar
AIAlon Israeli
Alon Israeli
MLMatan Levy
Matan Levy
HGHadas Ben Gera
Hadas Ben Gera
JJJosé M. Jiménez-Gómez
José M. Jiménez-Gómez
NONaomi Ori
Naomi Ori
The tomato CLAUSA gene encodes a unique MYB transcription factor that promotes leaf differentiation by attenuating cytokinin response.

13 January 2020 in Bioinformatics
Verified
Journal Article
Closed access
ŠKŠtěpán Kouřil
Štěpán Kouřil
JSJulie de Sousa
Julie de Sousa
JVJan Václavík
Jan Václavík
DFDavid Friedecky
David Friedecky
Tomáš AdamTomáš Adam
Tomáš Adam
Summary: Untargeted liquid chromatography–high-resolution mass spectrometry analysis produces a large number of features which correspond to the potential compounds in the sample that is analyzed. During the data processing, it is necessary to merge features associated with one compound to prevent multiplicities in the data and possible misidentification. The processing tools that are currently employed use complex algorithms to detect abundances, such as adducts or isotopes. However, most of them are not able to deal with unpredictable adducts and in-source fragments. We introduce a simple open-source R-script CROP based on Pearson pairwise correlations and retention time together with a graphical representation of the correlation network to remove these redundant features. Availability and implementation: The CROP R-script is available online at www.github.com/rendju/CROP under GNU GPL. Supplementary information: Supplementary data are available at Bioinformatics online.

14 April 2020 in JIMD Reports
Verified
Journal Article
Open access
PDF file
JVJan Václavík
Jan Václavík
LMLucie Mádrová
Lucie Mádrová
ŠKŠtěpán Kouřil
Štěpán Kouřil
JSJulie de Sousa
Julie de Sousa
RBRadana Brumarová
Radana Brumarová
Tomáš AdamTomáš Adam
Tomáš Adam
3‐Hydroxy‐3‐methylglutaryl‐coenzyme A lyase deficiency (HMGCLD) is a rare autosomal recessively inherited metabolic disorder. Patients suffer from avoidable neurologically devastating metabolic decompensations and thus would benefit from newborn screening (NBS). The diagnosis is currently made by measuring dry blood spot acylcarnitines (C5OH and C6DC) followed by urinary organic acid profiling for the differential diagnosis from several other disorders. Using untargeted metabolomics (reversed‐phase UHPLC coupled to an Orbitrap Elite hybrid mass spectrometer) of plasma samples from 5 HMGCLD patients and 19 age‐matched controls, we found 3‐methylglutaconic acid and 3‐hydroxy‐3‐methylglutaric acid, together with 3‐hydroxyisovalerylcarnitine as the most discriminating metabolites between the groups. In order to evaluate the NBS potential of these metabolites we quantified the most discriminating metabolites from untargeted metabolomics in 23 blood spots from 4 HMGCLD patients and 55 controls by UHPLC tandem mass spectrometry. The results provide a tool for expanded NBS of HMGCLD using tandem mass spectrometry. Selected reaction monitoring transition 262/85 could be used in a first‐tier NBS analysis to screen for elevated 3‐hydroxyisovalerylcarnitine. In a positive case, a second‐tier analysis of 3‐hydroxy‐3‐methylglutaric acid and 3‐methylglutaconic acid in a dry blood spot using UHPLC tandem mass spectrometry instruments confirms the diagnosis. In conclusion, we describe the identification of new diagnostic biomarkers for HMGCLD and their application in NBS in dry blood spots. By using second‐tier testing, all patients with HMGCLD were unequivocally and correctly diagnosed.

12 April 2019 in Planta
Verified
Journal Article
Closed access
PDF file
PJPavel Jaworek
Pavel Jaworek
DKDavid Kopečný
David Kopečný
DZDavid Zalabak
David Zalabak
MSMarek Sebela
Marek Sebela
ŠKŠtěpán Kouřil
Štěpán Kouřil
Petr TarkowskiPetr Tarkowski
Petr Tarkowski